Pliant Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
PLRX on Nasdaq
Location
260 Littlefield Avenue, South San Francisco, California

Insiders trading volume in the past year

Pliant Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures III, L.P. 10%+ Owner $68.4 M Nov 29, 2022
Bernard Coulie President and CEO, Director $14.7 M -$1.71 M -10.4% Jan 23, 2024
Hans Hull Chief Business Officer $4.04 M -$1.12 M -21.7% Jan 23, 2024
Eric Lefebvre Chief Medical Officer $3.44 M -$579 K -14.4% Jan 23, 2024
Mike Ouimette General Counsel & Corp. Sec'y $1.49 M -$403 K -21.2% Jan 23, 2024
Keith Lamont Cummings Chief Financial Officer $565 K -$525 K -48.1% May 2, 2024
Lily Cheung Chief Human Resource Officer $462 K Jan 23, 2024
E. Krognes Director $111 K Jun 13, 2024
Smital Shah Director $55.7 K Jun 13, 2024
Crowell G. A. Director $55.7 K Jun 13, 2024
Thomas A. MCCOURT Director $55.7 K Jun 13, 2024
Darren S. Cline Director $55.7 K Jun 13, 2024
Hoyoung Huh Director $55.7 K Jun 13, 2024
Suzanne Louise Bruhn Director $55.7 K Jun 13, 2024
John T. Curnutte Director $55.7 K Jun 13, 2024
D. E. I. Pyott Director $55.7 K Jun 13, 2024
Katharine Knobil Director $55.7 K Jun 13, 2024
Neil Exter Director Jun 16, 2022
Charles J. Homcy Director Jun 29, 2021

Recent Insider Transactions by Companies or Individuals for Pliant Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership